-
2
-
-
2442519348
-
Recent developments in the management of choroidal melanoma
-
Shields CL, Shields JA: Recent developments in the management of choroidal melanoma. Curr Opin Ophthalmol 2004, 15:244-251.
-
(2004)
Curr Opin Ophthalmol
, vol.15
, pp. 244-251
-
-
Shields, C.L.1
Shields, J.A.2
-
3
-
-
0025962917
-
Survival of patients with metastases from uveal melanoma
-
discussion 390
-
Gragoudas ES, Egan KM, Seddon JM, et al.: Survival of patients with metastases from uveal melanoma. Ophthalmology 1991, 98:383-389; discussion 390.
-
(1991)
Ophthalmology
, vol.98
, pp. 383-389
-
-
Gragoudas, E.S.1
Egan, K.M.2
Seddon, J.M.3
-
4
-
-
0142200859
-
Very long-term prognosis of patients with malignant uveal melanoma
-
Kujala E, Makitie T, Kivela T: Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003, 44:4651-4659.
-
(2003)
Invest Ophthalmol Vis Sci
, vol.44
, pp. 4651-4659
-
-
Kujala, E.1
Makitie, T.2
Kivela, T.3
-
5
-
-
0035025251
-
Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15
-
Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 2001, 119:670-676.
-
(2001)
Arch Ophthalmol
, vol.119
, pp. 670-676
-
-
-
6
-
-
33947230256
-
Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma
-
Liu W, Kelly JW, Trivett M, et al.: Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. J Invest Dermatol 2007, 127:900-905.
-
(2007)
J Invest Dermatol
, vol.127
, pp. 900-905
-
-
Liu, W.1
Kelly, J.W.2
Trivett, M.3
-
7
-
-
18444374405
-
Mutations of the BRAF gene in human cancer
-
Davies H, Bignell GR, Cox C, et al.: Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
-
(2002)
Nature
, vol.417
, pp. 949-954
-
-
Davies, H.1
Bignell, G.R.2
Cox, C.3
-
8
-
-
0141842689
-
Absence of BRAF and NRAS mutations in uveal melanoma
-
Cruz F III, Rubin BP, Wilson D, et al.: Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res 2003, 63:5761-5766.
-
(2003)
Cancer Res
, vol.63
, pp. 5761-5766
-
-
Cruz III, F.1
Rubin, B.P.2
Wilson, D.3
-
9
-
-
0141961836
-
Familial melanoma: A complex disorder leading to controversy on DNA testing
-
de Snoo FA, BArgman W, Gruis NA: Familial melanoma: a complex disorder leading to controversy on DNA testing. Fam Cancer 2003, 2:109-116.
-
(2003)
Fam Cancer
, vol.2
, pp. 109-116
-
-
de Snoo, F.A.1
Bergman, W.2
Gruis, N.A.3
-
10
-
-
0027946010
-
Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma
-
Ohta M, Nagai H, Shimizu M, et al.: Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 1994, 54:5269-5272.
-
(1994)
Cancer Res
, vol.54
, pp. 5269-5272
-
-
Ohta, M.1
Nagai, H.2
Shimizu, M.3
-
12
-
-
0031041186
-
Use of fluorescence in situ hybridization and comparative genomic hybridization in the cytogenetic analysis of testicular germ cell tumors and uveal melanomas
-
Becher R, Korn WM, Prescher G: Use of fluorescence in situ hybridization and comparative genomic hybridization in the cytogenetic analysis of testicular germ cell tumors and uveal melanomas. Cancer Genet Cytogenet 1997, 93:22-28.
-
(1997)
Cancer Genet Cytogenet
, vol.93
, pp. 22-28
-
-
Becher, R.1
Korn, W.M.2
Prescher, G.3
-
13
-
-
0035870290
-
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma
-
Tschentscher F, Prescher G, Horsman DE, et al.: Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res 2001, 61:3439-3442.
-
(2001)
Cancer Res
, vol.61
, pp. 3439-3442
-
-
Tschentscher, F.1
Prescher, G.2
Horsman, D.E.3
-
14
-
-
0033954096
-
Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma
-
Sisley K, Parsons MA, Garnham J, et al.: Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma. Br J Cancer 2000, 82:330-338.
-
(2000)
Br J Cancer
, vol.82
, pp. 330-338
-
-
Sisley, K.1
Parsons, M.A.2
Garnham, J.3
-
15
-
-
0033008658
-
C-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma
-
Chana JS, Wilson GD, Cree IA, et al.: C-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Br J Ophthalmol 1999, 83:110-114.
-
(1999)
Br J Ophthalmol
, vol.83
, pp. 110-114
-
-
Chana, J.S.1
Wilson, G.D.2
Cree, I.A.3
-
16
-
-
0033168843
-
Allelotype of posterior uveal melanoma: Implications for a bifurcated tumor progression pathway
-
Parrella P, Sidransky D, Merbs SL: Allelotype of posterior uveal melanoma: Implications for a bifurcated tumor progression pathway. Cancer Res 1999, 59:3032-3037.
-
(1999)
Cancer Res
, vol.59
, pp. 3032-3037
-
-
Parrella, P.1
Sidransky, D.2
Merbs, S.L.3
-
17
-
-
0345256382
-
Dissecting karyotypic patterns in malignant melanomas: Temporal clustering of losses and gains in melanoma karyotypic evolution
-
Hoglund M, Gisselsson D, Hansen GB, et al.: Dissecting karyotypic patterns in malignant melanomas: Temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 2004, 108:57-65.
-
(2004)
Int J Cancer
, vol.108
, pp. 57-65
-
-
Hoglund, M.1
Gisselsson, D.2
Hansen, G.B.3
-
19
-
-
0029874486
-
Prognostic implications of monosomy 3 in uveal melanoma
-
Prescher G, Bornfeld N, Hirche H, et al.: Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996, 347:1222-1225.
-
(1996)
Lancet
, vol.347
, pp. 1222-1225
-
-
Prescher, G.1
Bornfeld, N.2
Hirche, H.3
-
20
-
-
5644251671
-
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death
-
Onken MD, Worley LA, Ehlers JP, Harbour JW: Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004, 64:7205-7209.
-
(2004)
Cancer Res
, vol.64
, pp. 7205-7209
-
-
Onken, M.D.1
Worley, L.A.2
Ehlers, J.P.3
Harbour, J.W.4
-
21
-
-
33646405726
-
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas
-
Onken MD, Ehlers JP, Worley LA, et al.: Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 2006, 66:4602-4609.
-
(2006)
Cancer Res
, vol.66
, pp. 4602-4609
-
-
Onken, M.D.1
Ehlers, J.P.2
Worley, L.A.3
-
22
-
-
36049030601
-
Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma
-
Zuidervaart W, Pavey S, van Nieuwpoort FA, et al.: Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. Melanoma Res 2007, 17:380-386.
-
(2007)
Melanoma Res
, vol.17
, pp. 380-386
-
-
Zuidervaart, W.1
Pavey, S.2
van Nieuwpoort, F.A.3
-
23
-
-
33644873740
-
Metastatic uveal melanoma therapy: Current options
-
Bedikian AY: Metastatic uvealCmelanoma therapy: current options. Int Ophthalmol Clin 2006, 46:151-166.
-
(2006)
Int Ophthalmol Clin
, vol.46
, pp. 151-166
-
-
Bedikian, A.Y.1
-
24
-
-
0028853939
-
Treatment of uveal melanoma metastatic to the liver: A review of the M.D. Anderson Cancer Center experience and prognostic factors
-
Bedikian AY, Legha SS, Mavligit G, et al.: Treatment of uveal melanoma metastatic to the liver: A review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 1995, 76:1665-1670.
-
(1995)
Cancer
, vol.76
, pp. 1665-1670
-
-
Bedikian, A.Y.1
Legha, S.S.2
Mavligit, G.3
-
25
-
-
0034307203
-
Protracted survival after resection of metastatic uveal melanoma
-
Aoyama T, Mastrangelo MJ, Berd D, et al.: Protracted survival after resection of metastatic uveal melanoma. Cancer 2000, 89:1561-1568.
-
(2000)
Cancer
, vol.89
, pp. 1561-1568
-
-
Aoyama, T.1
Mastrangelo, M.J.2
Berd, D.3
-
26
-
-
17144438510
-
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy
-
Leyvraz S, Spataro V, Bauer J, et al.: Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997, 15:2589-2595.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2589-2595
-
-
Leyvraz, S.1
Spataro, V.2
Bauer, J.3
-
27
-
-
0028352232
-
Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study
-
Cantore M, Fiorentini G, Aitini E, et al.: Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumori 1994, 80:37-39.
-
(1994)
Tumori
, vol.80
, pp. 37-39
-
-
Cantore, M.1
Fiorentini, G.2
Aitini, E.3
-
28
-
-
0033875498
-
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver
-
Alexander HR, Libutti SK, Bartlett DL, et al.: A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2000, 6:3062-3070.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3062-3070
-
-
Alexander, H.R.1
Libutti, S.K.2
Bartlett, D.L.3
-
29
-
-
0023687302
-
Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge
-
Mavligit GM, Charnsangavej C, Carrasco CH, et al.: Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 1988, 260:974-976.
-
(1988)
JAMA
, vol.260
, pp. 974-976
-
-
Mavligit, G.M.1
Charnsangavej, C.2
Carrasco, C.H.3
-
30
-
-
23744445248
-
Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: Results of a phase II study
-
Patel K, Sullivan K, Berd D, et al.: Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: Results of a phase II study. Melanoma Res 2005, 15:297-304.
-
(2005)
Melanoma Res
, vol.15
, pp. 297-304
-
-
Patel, K.1
Sullivan, K.2
Berd, D.3
-
31
-
-
56749158015
-
Immunoembolization of malignant liver tumors using granulocyte-macrophage colony-stimulating factor (GM-CSF, Ssargramostim): A novel treatment for uveal melanoma patients with hepatic metastases
-
[In press]
-
Sato T, Eschelman DJ, Gonsalves CF, et al.: Immunoembolization of malignant liver tumors using granulocyte-macrophage colony-stimulating factor (GM-CSF, Ssargramostim): A novel treatment for uveal melanoma patients with hepatic metastases. J Clin Oncol 2008 [In press].
-
(2008)
J Clin Oncol
-
-
Sato, T.1
Eschelman, D.J.2
Gonsalves, C.F.3
-
32
-
-
58649113834
-
Treatment of uveal melanoma liver metastases using Y-90 SIR-Spheres: Imaging and clinical response
-
[abstract 128]
-
Gonsalves CF, Sullivan K, Eschelman DJ, et al.: Treatment of uveal melanoma liver metastases using Y-90 SIR-Spheres: Imaging and clinical response [abstract 128]. J Vasc Interv Radiol 2008, 19:S50.
-
(2008)
J Vasc Interv Radiol
, vol.19
-
-
Gonsalves, C.F.1
Sullivan, K.2
Eschelman, D.J.3
-
33
-
-
0026793058
-
Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor
-
Natali PG, Nicotra MR, Winkler AB, et al.: Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 1992, 52:197-201.
-
(1992)
Int J Cancer
, vol.52
, pp. 197-201
-
-
Natali, P.G.1
Nicotra, M.R.2
Winkler, A.B.3
-
34
-
-
0030813188
-
Molecular mechanisms of melanoma metastasis
-
Bar-Eli M: Molecular mechanisms of melanoma metastasis. J Cell Physiol 1997, 173:275-278.
-
(1997)
J Cell Physiol
, vol.173
, pp. 275-278
-
-
Bar-Eli, M.1
-
35
-
-
9144267709
-
Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays
-
Pache M, Glatz K, Bosch D, et al.: Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays. Virchows Arch 2003, 443:741-744.
-
(2003)
Virchows Arch
, vol.443
, pp. 741-744
-
-
Pache, M.1
Glatz, K.2
Bosch, D.3
-
36
-
-
0038580772
-
Expression of the c-kit receptor in choroidal melanomas
-
Mouriaux F, Kherrouche Z, Maurage CA, et al.: Expression of the c-kit receptor in choroidal melanomas. Melanoma Res 2003, 13:161-166.
-
(2003)
Melanoma Res
, vol.13
, pp. 161-166
-
-
Mouriaux, F.1
Kherrouche, Z.2
Maurage, C.A.3
-
37
-
-
0034769738
-
Implication of stem cell factor in the proliferation of choroidal melanocytes
-
Mouriaux F, Chahud F, Maurage CA, et al.: Implication of stem cell factor in the proliferation of choroidal melanocytes. Exp Eye Res 2001, 73:151-157.
-
(2001)
Exp Eye Res
, vol.73
, pp. 151-157
-
-
Mouriaux, F.1
Chahud, F.2
Maurage, C.A.3
-
38
-
-
3843116637
-
Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis
-
Lefevre G, Glotin AL, Calipel A, et al.: Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis. J Biol Chem 2004, 279:31769-31779.
-
(2004)
J Biol Chem
, vol.279
, pp. 31769-31779
-
-
Lefevre, G.1
Glotin, A.L.2
Calipel, A.3
-
39
-
-
58649119814
-
A pilot study using sunitinib malate as therapy in patients with stage IV uveal melanoma
-
[abstract 9047]
-
Chan KR, Gundala S, Laudadio M, et al.: A pilot study using sunitinib malate as therapy in patients with stage IV uveal melanoma [abstract 9047]. J Clin Oncol 2008, 26(15S):494s.
-
(2008)
J Clin Oncol
, vol.26
, Issue.15 S
-
-
Chan, K.R.1
Gundala, S.2
Laudadio, M.3
-
40
-
-
33947311526
-
Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: An immunohistochemical study
-
Mallikarjuna K, Pushparaj V, Biswas J, et al.: Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: An immunohistochemical study. Curr Eye Res 2007, 32:281-290.
-
(2007)
Curr Eye Res
, vol.32
, pp. 281-290
-
-
Mallikarjuna, K.1
Pushparaj, V.2
Biswas, J.3
-
41
-
-
33846999668
-
Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF
-
Di Cesare S, Marshall JC, Logan P, et al.: Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF. J Carcinog 2007, 6:2.
-
(2007)
J Carcinog
, vol.6
, pp. 2
-
-
Di Cesare, S.1
Marshall, J.C.2
Logan, P.3
-
42
-
-
33745697763
-
Targeting the c-Met signaling pathway in cancer
-
Peruzzi B, Bottaro DP: Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 2006, 12:3657-3660.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 3657-3660
-
-
Peruzzi, B.1
Bottaro, D.P.2
-
43
-
-
33644815365
-
Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: Intercorrelation and prognostic implications
-
Economou MA, All-Ericsson C, Bykov V, et al.: Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Invest Ophthalmol Vis Sci 2005, 46:4372-4375.
-
(2005)
Invest Ophthalmol Vis Sci
, vol.46
, pp. 4372-4375
-
-
Economou, M.A.1
All-Ericsson, C.2
Bykov, V.3
-
44
-
-
0036138625
-
Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target
-
All-Ericsson C, Girnita L, Seregard S, et al.: Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci 2002, 43:1-8.
-
(2002)
Invest Ophthalmol Vis Sci
, vol.43
, pp. 1-8
-
-
All-Ericsson, C.1
Girnita, L.2
Seregard, S.3
-
45
-
-
33750369197
-
Insulin-like growth factor-I axis as a pathway for cancer chemoprevention
-
Adhami VM, Afaq F, Mukhtar H: Insulin-like growth factor-I axis as a pathway for cancer chemoprevention. Clin Cancer Res 2006, 12:5611-5614.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5611-5614
-
-
Adhami, V.M.1
Afaq, F.2
Mukhtar, H.3
-
46
-
-
33644751770
-
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells
-
Girnita A, All-Ericsson C, Economou MA, et al.: The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clin Cancer Res 2006, 12:1383-1391.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1383-1391
-
-
Girnita, A.1
All-Ericsson, C.2
Economou, M.A.3
-
47
-
-
33644822256
-
High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma
-
Abdel-Rahman MH, Yang Y, Zhou XP, et al.: High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma. J Clin Oncol 2006, 24:288-295.
-
(2006)
J Clin Oncol
, vol.24
, pp. 288-295
-
-
Abdel-Rahman, M.H.1
Yang, Y.2
Zhou, X.P.3
-
48
-
-
23744472959
-
Immunohistochemical expression of phospho-Akt in uveal melanoma
-
Saraiva VS, Caissie AL, Segal L, et al.: Immunohistochemical expression of phospho-Akt in uveal melanoma. Melanoma Res 2005, 15:245-250.
-
(2005)
Melanoma Res
, vol.15
, pp. 245-250
-
-
Saraiva, V.S.1
Caissie, A.L.2
Segal, L.3
-
49
-
-
32944465388
-
Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway
-
Granville CA, Memmott RM, Gills JJ, et al.: Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway. Clin Cancer Res 2006, 12(3 Pt 1):679-689.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.3 PART 1
, pp. 679-689
-
-
Granville, C.A.1
Memmott, R.M.2
Gills, J.J.3
-
50
-
-
23844476134
-
CCI-779 in metastatic melanoma: A phase II trial of the California Cancer Consortium
-
Margolin K, Longmate J, Baratta T, et al.: CCI-779 in metastatic melanoma: A phase II trial of the California Cancer Consortium. Cancer 2005, 104:1045-1048.
-
(2005)
Cancer
, vol.104
, pp. 1045-1048
-
-
Margolin, K.1
Longmate, J.2
Baratta, T.3
|